Xolair - Drug Details
๐Ÿ“Š Estimates Xolair Dialyzability By Different_Modalities

Xolair

Complete Drug Information

Drug Name
Xolair
Trade Names
Xolair
Pregnancy Category
AU: B1
Routes of Administration
Subcutaneous
Elimination
26 days
Formula
C6450H9916N1714O2023S38
Molar Mass
145058.53
Volume of Distribution
C6450H9916N1714O2023S38

๐Ÿคฐ Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.